Launching X–Labs for Breakthrough Science Act
Summary
What This Bill Does
The Launching X-Labs for Breakthrough Science Act creates a new NIH X-Labs Initiative in Public Health Service Act title IV. NIH would provide long-term institutional awards to eligible entities to conduct breakthrough biomedical research and acquire research and development plant. The Director must create an XL-series activity code available across NIH institutes and centers. Award categories include XL01 for basic science research institutions needing stable long-term funding, XL02 for science institutions developing datasets, measurement tools, or techniques with defined deliverables, XL03 for nonprofit institutions that fund focused research organizations, individual researchers, research collaborations, or centers, and XL04 for forming and planning new scientific institutions that may later qualify for other categories. The bill defines eligible entities, breakthrough biomedical research, basic science research institution, focused research organization, R&D plant, and oversight terms, and requires award conditions, reporting, and oversight through NIH mechanisms.
Who Benefits and How
Basic science research institutions benefit from stable long-term XL01 support with less budgetary reprogramming pressure. Science institutions benefit from XL02 awards for datasets, measurement tools, and techniques. Nonprofit funders of focused research organizations benefit from XL03 awards. New scientific ventures benefit from XL04 formation and planning support. Biomedical researchers benefit from institutional funding aimed at high-risk breakthrough work. Patients benefit indirectly if breakthrough research leads to better understanding, tools, or treatments.
Who Bears the Burden and How
NIH program officials must create the X-Labs Initiative, manage XL-series activity codes, compete and oversee awards, review eligible entities, and enforce reporting requirements. NIH institutes and centers must administer award categories and oversight. Federal taxpayers bear multi-year institutional award costs. Award recipients must comply with eligibility, reporting, deliverable, and oversight conditions. New institutions must plan around federal requirements before becoming eligible for larger awards.
Key Provisions
- Establishes the NIH X-Labs Initiative for long-term institutional awards.
- Creates XL01, XL02, XL03, and XL04 award categories for basic science, scientific resources, focused research, and new institutions.
- Directs NIH to designate an XL-series activity code available across institutes and centers.
- Supports acquisition of R&D plant needed for breakthrough biomedical research.
- Requires NIH oversight, eligibility rules, award conditions, and reporting.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
Creates an NIH X-Labs Initiative providing long-term institutional awards for breakthrough biomedical research, scientific resources, focused-research organizations, and new scientific institutions, with XL-series activity codes, eligibility rules, oversight, and reporting.
Key Policy Areas
Biomedical Research, NIH, Grants
Primary Purpose
Creates an NIH X-Labs Initiative providing long-term institutional awards for breakthrough biomedical research, scientific resources, focused-research organizations, and new scientific institutions, with XL-series activity codes, eligibility rules, oversight, and reporting.
Policy Domains
Substantive provisions
Identified Gains
- Basic science research institutions
- Science institutions developing datasets
- Focused research organizations
- New scientific ventures
- Biomedical researchers
- Patients
Identified Costs
- NIH program officials
- NIH institutes
- Federal taxpayers
- Award recipients
- New scientific institutions
Sponsors
Josh Harder
D-CA | Primary Sponsor
Legislative Progress
In CommitteeReferred to the House Committee on Energy and Commerce.
Introduced in House
Mr. Harder of California (for himself and Mr. Obernolte) introduced …
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Award recipients, Basic science research institutions, Focused research organizations
Positive-direction: Basic science research institutions, Focused research organizations, New scientific ventures, Science institutions developing datasets
Negative-direction: Award recipients
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "agencies"
- → ['NIH']
- "programs"
- → ['X-Labs Initiative']
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology